A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated ...

The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

Respiratory Syncytial Virus is a growing health concern for Indian infants. Efforts for maternal RSV vaccine faces challenges ...

Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the US Food and Drug Administration (FDA) ...

Early evidence shows that nirsevimab substantially reduced emergency bronchiolitis cases and hospital admissions in infants ...